Renal cell carcinoma: etiology, incidence and epidemiology
- PMID: 15205579
- DOI: 10.1097/01.mou.0000135078.04721.f5
Renal cell carcinoma: etiology, incidence and epidemiology
Abstract
Purpose of review: The incidence of renal cell carcinoma has been increasing worldwide. Although the etiology of renal cell carcinoma is largely unknown, recent epidemiological investigations have shed some light on the issue. This article reviews the literature related to etiology, incidence and epidemiology of renal cell carcinoma published between May 1, 2003 and April 30, 2004.
Recent findings: Accumulating evidence has confirmed the increasing incidence of renal cell carcinoma. A racial disparity has been reported for the first time. Being overweight and obesity were confirmed to be risk factors for renal cell carcinoma. Recreational exercise was shown to reduce the risk, whereas a Western-style diet and smoking increased the risk. Occupational exposure may relate to the development of renal cell carcinoma; however, no definite carcinogens have so far been identified. A susceptibility to develop renal cell carcinoma may also exist in relation to the gene polymorphisms of detoxifying enzymes including glutathione S-transferase and cytochrome P450.
Summary: Although high-risk groups for renal cell carcinoma have been identified, a large portion of renal cell carcinoma still has an unknown etiology. Life-style modifications might reduce renal cell carcinoma risks. Further studies are thus needed to explore the etiology of renal cell carcinoma in terms of gene-environment interactions.
Similar articles
-
Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review.Cancer Invest. 2005;23(3):240-55. doi: 10.1081/cnv-200055962. Cancer Invest. 2005. PMID: 15945510 Review.
-
[Exogenous risk factors for parenchymal carcinoma of the kidney].Arch Ital Urol Androl. 2001 Mar;73(1):49-55. Arch Ital Urol Androl. 2001. PMID: 11505815 Review. Italian.
-
Epidemiology and risk factors for kidney cancer.Nat Rev Urol. 2010 May;7(5):245-57. doi: 10.1038/nrurol.2010.46. Nat Rev Urol. 2010. PMID: 20448658 Free PMC article. Review.
-
Human renal-cell carcinoma--epidemiological and mechanistic aspects.IARC Sci Publ. 1999;(147):69-80. IARC Sci Publ. 1999. PMID: 10457911 Review. No abstract available.
-
Epidemiologic aspects of renal cell cancer.Semin Oncol. 2000 Apr;27(2):115-23. Semin Oncol. 2000. PMID: 10768591 Review.
Cited by
-
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?J Exp Clin Cancer Res. 2015 Feb 5;34(1):10. doi: 10.1186/s13046-015-0122-0. J Exp Clin Cancer Res. 2015. PMID: 25651794 Free PMC article.
-
Targeting newly identified ERβ/TGF-β1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.Mol Oncol. 2018 Dec;12(12):2055-2071. doi: 10.1002/1878-0261.12377. Epub 2018 Oct 30. Mol Oncol. 2018. PMID: 30171816 Free PMC article.
-
Immunotherapeutic strategies in kidney cancer--when TKIs are not enough.Nat Rev Clin Oncol. 2009 Aug;6(8):478-87. doi: 10.1038/nrclinonc.2009.91. Epub 2009 Jun 23. Nat Rev Clin Oncol. 2009. PMID: 19546865 Review.
-
LncRNA LINC00944 Promotes Tumorigenesis but Suppresses Akt Phosphorylation in Renal Cell Carcinoma.Front Mol Biosci. 2021 Jul 5;8:697962. doi: 10.3389/fmolb.2021.697962. eCollection 2021. Front Mol Biosci. 2021. PMID: 34291088 Free PMC article.
-
Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway.Oncol Res. 2017 May 24;25(5):773-779. doi: 10.3727/096504016X14774889687280. Epub 2016 Nov 8. Oncol Res. 2017. PMID: 27983909 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous